DoW Alzheimer’s Transforming Care Award
DoW Alzheimer’s Transforming Care Award is a published development and funding opportunity on Contexium. The donor or funder is Defense Health Agency Contracting Activity - DHACA. Project location(s): United States. Applications close on 24 Sep 2026. Summary: The fiscal year 2026 (FY26) Alzheimer’s Research Program (AZRP) Transforming Care Award (TrCA) supports clinical research or clinical trials evaluating interventions, innovations, and solutions in critical areas for dementia care for individuals with Alzheimer’s disease and Alzheimer’s dise…
Opportunity overview
- Project name
- DoW Alzheimer’s Transforming Care Award
- Donor
- Defense Health Agency Contracting Activity - DHACA
Key details
- Opportunity start date
- Opportunity end date
- Project location(s)
- United States
Summary
Frequently asked questions
What is DoW Alzheimer’s Transforming Care Award?
DoW Alzheimer’s Transforming Care Award is a published development and funding opportunity on Contexium. The donor or funder is Defense Health Agency Contracting Activity - DHACA. Project location(s): United States. Applications close on 24 Sep 2026. Summary: The fiscal year 2026 (FY26) Alzheimer’s Research Program (AZRP) Transforming Care Award (TrCA) supports clinical research or clinical trials evaluating interventions, innovations, and solutions in critical areas for dementia care for individuals with Alzheimer’s disease and Alzheimer’s dise…
Who is funding DoW Alzheimer’s Transforming Care Award?
DoW Alzheimer’s Transforming Care Award is funded by Defense Health Agency Contracting Activity - DHACA.
When is the deadline to apply for DoW Alzheimer’s Transforming Care Award?
The application deadline is 24 Sep 2026 00:00 (UTC).
Where will the DoW Alzheimer’s Transforming Care Award project take place?
The project location(s) are: United States.
How can I apply for DoW Alzheimer’s Transforming Care Award?
Create a free Contexium account to view the full opportunity details and submit an application via the marketplace.